- £595.24m
- £566.27m
- £202.53m
- 94
- 19
- 92
- 82
Annual income statement for Cohort, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 131 | 143 | 138 | 183 | 203 |
| Cost of Revenue | |||||
| Gross Profit | 51 | 53.4 | 56.6 | 64.9 | 76.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 120 | 136 | 127 | 167 | 181 |
| Operating Profit | 10.7 | 7.81 | 11.1 | 15.3 | 21.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.98 | 7.06 | 10.2 | 13.9 | 19.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.68 | 5.5 | 8.69 | 11.3 | 15.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.56 | 5.46 | 9.2 | 11.4 | 15.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.56 | 5.46 | 9.2 | 11.4 | 15.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.214 | 0.127 | 0.239 | 0.279 | 0.377 |
| Dividends per Share |